bf/NYSE:TMO_icon.jpeg

COM:THERMOFISHER

Thermo Fisher Scientific Inc.

  • Stock

USD

Last Close

516.10

22/11 21:00

Market Cap

204.93B

Beta: -

Volume Today

1.61M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.47B
-
1.68B
14.17%
1.93B
14.82%
2.10B
9.19%
2.59B
23.29%
2.99B
15.27%
3.19B
6.68%
3.70B
16.06%
4.54B
22.72%
5.34B
17.68%
5.36B
0.35%
average payables
666.45M
-
756.10M
13.45%
821.45M
8.64%
874.20M
6.42%
1.18B
34.65%
1.52B
29.26%
1.77B
16.17%
2.05B
15.84%
2.52B
23.13%
3.12B
23.92%
3.13B
0.08%
average receivables
1.87B
-
2.21B
17.85%
2.51B
13.65%
2.80B
11.46%
3.46B
23.85%
4.01B
15.70%
4.24B
5.86%
5.04B
18.92%
6.86B
35.96%
8.13B
18.46%
8.82B
8.60%
book value per share
46.78
-
51.60
10.30%
53.55
3.77%
54.56
1.88%
64.34
17.92%
68.62
6.66%
74.19
8.11%
87.14
17.46%
85.13
2.31%
112.33
31.95%
120.42
7.21%
capex per share
-0.78
-
-1.07
37.00%
-1.06
1.22%
-1.13
6.12%
-1.29
14.25%
-1.89
46.61%
-2.31
22.77%
-3.72
60.79%
-6.40
72.04%
-5.72
10.64%
-3.81
33.38%
capex to depreciation
-0.28
-
-0.25
10.14%
-0.25
1.30%
-0.25
0.91%
-0.25
1.15%
-0.33
33.81%
-0.41
21.63%
-0.63
55.89%
-0.97
53.54%
-0.66
31.84%
-0.43
34.55%
capex to operating cash flow
-0.14
-
-0.16
16.22%
-0.15
8.03%
-0.14
6.22%
-0.13
9.91%
-0.17
31.54%
-0.19
11.60%
-0.18
4.50%
-0.26
48.67%
-0.25
7.32%
-0.18
28.19%
capex to revenue
-0.02
-
-0.03
17.36%
-0.02
1.54%
-0.02
2.44%
-0.02
0.14%
-0.03
28.14%
-0.04
16.50%
-0.05
26.20%
-0.06
40.64%
-0.05
22.39%
-0.03
30.90%
cash per share
16.18
-
3.40
79.02%
1.13
66.60%
1.99
75.62%
3.38
69.72%
5.23
54.79%
6.00
14.65%
26.07
334.74%
11.36
56.42%
21.74
91.37%
20.82
4.27%
days of inventory on hand
74.33
-
75.66
1.80%
82.77
9.40%
85.41
3.18%
98.93
15.84%
84.41
14.68%
89.69
6.25%
93.59
4.35%
97.15
3.80%
80.91
16.71%
67.21
16.94%
days payables outstanding
34.39
-
33.39
2.90%
34.17
2.33%
35.74
4.59%
47.55
33.05%
45.37
4.60%
51.10
12.64%
50.52
1.12%
55.14
9.14%
48.56
11.94%
37.94
21.87%
days sales outstanding
54.16
-
53.46
1.29%
54.75
2.42%
60.89
11.21%
67.69
11.16%
61.98
8.43%
62.15
0.28%
65.04
4.65%
74.25
14.17%
67.24
9.45%
70.02
4.13%
debt to assets
0.33
-
0.34
3.82%
0.31
10.55%
0.36
18.73%
0.37
2.34%
0.34
8.95%
0.31
9.75%
0.31
3.18%
0.37
16.87%
0.35
3.64%
0.35
0.23%
debt to equity
0.62
-
0.71
13.92%
0.59
17.22%
0.77
31.57%
0.83
7.08%
0.69
16.73%
0.60
13.10%
0.63
5.29%
1.04
65.05%
0.78
24.66%
0.75
4.59%
dividend yield
0.01
-
0.00
12.67%
0.00
9.61%
0.00
0.60%
0.00
26.16%
0.00
6.43%
0.00
22.70%
0.00
20.06%
0.00
17.76%
0.00
40.28%
0.00
20.48%
earnings yield
0.03
-
0.04
19.64%
0.03
8.01%
0.04
3.91%
0.03
18.26%
0.03
10.09%
0.03
12.91%
0.03
21.52%
0.03
14.98%
0.03
9.56%
0.03
9.58%
enterprise value
44.78B
-
63.11B
40.93%
68.63B
8.75%
71.55B
4.25%
94.68B
32.32%
106.85B
12.86%
145.30B
35.99%
195.86B
34.80%
293.29B
49.74%
241.83B
17.54%
232.79B
3.74%
enterprise value over ebitda
16.84
-
17.27
2.57%
16.52
4.37%
16.11
2.46%
18.38
14.08%
17.11
6.93%
21.98
28.50%
19.20
12.66%
24.11
25.57%
20.06
16.79%
21.71
8.21%
ev to operating cash flow
22.27
-
24.09
8.17%
24.36
1.13%
22.67
6.96%
23.64
4.28%
23.52
0.51%
29.22
24.23%
23.63
19.13%
30.73
30.07%
26.42
14.04%
27.69
4.82%
ev to sales
3.42
-
3.74
9.23%
4.05
8.26%
3.92
3.21%
4.53
15.60%
4.39
3.08%
5.69
29.68%
6.08
6.86%
7.48
23.04%
5.38
28.01%
5.43
0.88%
free cash flow per share
4.80
-
5.50
14.76%
6.00
9.08%
6.87
14.40%
8.85
28.88%
9.42
6.35%
10.12
7.46%
17.21
70.10%
17.82
3.53%
17.63
1.05%
17.85
1.26%
free cash flow yield
0.04
-
0.04
1.99%
0.04
3.66%
0.05
15.01%
0.05
4.23%
0.04
9.76%
0.03
25.98%
0.04
18.64%
0.03
27.73%
0.03
19.89%
0.03
5.06%
graham net net
-19.39
-
-45.09
132.56%
-40.75
9.61%
-50.96
25.04%
-64.42
26.42%
-54.45
15.48%
-52.92
2.80%
-45.20
14.59%
-207.32
358.66%
-90.80
56.20%
-90.46
0.38%
graham number
60.99
-
74.32
21.85%
77.26
3.96%
79.29
2.62%
90.30
13.89%
106.23
17.64%
124.19
16.91%
177.66
43.05%
193.79
9.08%
211.68
9.23%
204.61
3.34%
income quality
1.57
-
1.38
12.08%
1.42
2.93%
1.56
9.56%
1.80
15.34%
1.55
13.98%
1.35
12.98%
1.30
3.36%
1.23
5.03%
1.32
6.51%
1.40
6.61%
intangibles to total assets
0.61
-
0.77
25.85%
0.77
0.31%
0.77
0.05%
0.74
3.68%
0.72
3.23%
0.68
4.88%
0.56
17.86%
0.65
16.70%
0.60
7.91%
0.61
1.99%
interest coverage
6.14
-
5.22
15.07%
5.63
7.96%
5.22
7.37%
5.01
3.87%
5.67
13.13%
6.80
19.82%
14.09
107.39%
18.71
32.74%
11.56
38.21%
5.32
53.96%
interest debt per share
29.83
-
37.78
26.63%
32.46
14.08%
43.31
33.42%
54.68
26.27%
48.90
10.58%
46.07
5.78%
56.28
22.17%
89.86
59.66%
89.83
0.03%
93.54
4.12%
inventory turnover
4.91
-
4.82
1.76%
4.41
8.59%
4.27
3.08%
3.69
13.67%
4.32
17.21%
4.07
5.88%
3.90
4.17%
3.76
3.66%
4.51
20.07%
5.43
20.39%
invested capital
0.62
-
0.71
13.92%
0.59
17.22%
0.77
31.57%
0.83
7.08%
0.69
16.73%
0.60
13.10%
0.63
5.29%
1.04
65.05%
0.78
24.66%
0.75
4.59%
market cap
40.12B
-
49.89B
24.35%
56.56B
13.36%
55.71B
1.50%
75.00B
34.64%
89.96B
19.95%
129.95B
44.45%
184.45B
41.94%
262.89B
42.53%
215.87B
17.89%
205.95B
4.60%
net current asset value
-5.14B
-
-15.69B
205.50%
-13.95B
11.07%
-17.34B
24.30%
-21.74B
25.35%
-17.95B
17.41%
-16.65B
7.26%
-12.59B
24.41%
-74.60B
492.63%
-27.78B
62.77%
-27.30B
1.74%
net debt to ebitda
1.75
-
3.62
106.42%
2.91
19.68%
3.57
22.75%
3.82
7.06%
2.70
29.21%
2.32
14.09%
1.12
51.85%
2.50
123.37%
2.15
13.79%
2.50
16.21%
net income per share
3.53
-
4.76
34.62%
4.95
4.14%
5.12
3.36%
5.63
9.99%
7.31
29.75%
9.24
26.43%
16.10
74.23%
19.61
21.79%
17.73
9.57%
15.45
12.85%
operating cash flow per share
5.58
-
6.58
17.88%
7.07
7.40%
7.99
13.16%
10.14
26.82%
11.30
11.46%
12.43
10.01%
20.93
68.36%
24.22
15.71%
23.35
3.59%
21.66
7.22%
payables turnover
10.61
-
10.93
2.99%
10.68
2.27%
10.21
4.39%
7.68
24.84%
8.05
4.82%
7.14
11.22%
7.22
1.14%
6.62
8.38%
7.52
13.57%
9.62
28.00%
receivables turnover
6.74
-
6.83
1.31%
6.67
2.37%
5.99
10.08%
5.39
10.04%
5.89
9.21%
5.87
0.27%
5.61
4.45%
4.92
12.41%
5.43
10.44%
5.21
3.97%
research and ddevelopement to revenue
0.03
-
0.04
35.43%
0.04
0.27%
0.04
1.22%
0.04
2.78%
0.04
6.48%
0.04
1.09%
0.04
6.65%
0.04
2.18%
0.03
8.66%
0.03
4.74%
return on tangible assets
0.10
-
0.20
88.94%
0.21
7.31%
0.19
8.59%
0.15
20.63%
0.19
21.71%
0.20
8.05%
0.21
5.00%
0.24
12.19%
0.18
23.76%
0.16
12.34%
revenue per share
36.33
-
42.41
16.74%
42.55
0.32%
46.29
8.78%
52.96
14.41%
60.59
14.42%
63.85
5.39%
81.36
27.41%
99.52
22.32%
114.58
15.13%
110.46
3.60%
roe
0.08
-
0.09
22.05%
0.09
0.36%
0.09
1.45%
0.09
6.72%
0.11
21.64%
0.12
16.94%
0.18
48.33%
0.23
24.67%
0.16
31.47%
0.13
18.71%
roic
0.04
-
0.06
52.86%
0.05
18.62%
0.05
13.11%
0.04
8.92%
0.05
27.10%
0.06
22.05%
0.09
41.12%
0.09
4.62%
0.07
18.31%
0.06
13.00%
sales general and administrative to revenue
shareholders equity per share
46.78
-
51.60
10.30%
53.55
3.77%
54.56
1.88%
64.34
17.92%
68.62
6.66%
74.19
8.11%
87.14
17.46%
85.13
2.31%
112.33
31.95%
120.42
7.21%
stock based compensation to revenue
0.01
-
0.01
0.16%
0.01
6.27%
0.01
0.85%
0.01
4.05%
0.01
2.24%
0.01
4.64%
0.01
14.15%
0.01
3.58%
0.01
16.53%
0.01
5.10%
tangible asset value
-2.72B
-
-12.40B
356.30%
-10.19B
17.84%
-13.76B
34.98%
-16.56B
20.38%
-12.74B
23.08%
-10.05B
21.08%
-4.22B
58.03%
-61.91B
1,367.53%
-14.49B
76.60%
-13.85B
4.43%
tangible book value per share
-7.55
-
-31.15
312.87%
-25.56
17.94%
-34.85
36.32%
-41.93
20.32%
-31.69
24.42%
-25.13
20.69%
-10.65
57.61%
-157.14
1,374.98%
-36.96
76.48%
-35.69
3.45%
working capital
3.58B
-
997M
72.12%
1.55B
55.59%
2.17B
40.06%
2.44B
12.26%
4.42B
81.10%
5.66B
28.16%
11.65B
105.85%
6.73B
42.28%
8.25B
22.67%
10.58B
28.19%

All numbers in USD (except ratios and percentages)